| 國立成功大學 |
2024-11 |
Cytoplasmic Lipid Droplets Predict Worse Prognosis in Diffuse Large B-Cell Lymphoma
|
Wang;Shu-Hsien;Chiang;Po-Min;Su;Yung-Yeh;Yu;Yu-Ting;Chen;Ya-Ping;Chen;Tsai-Yun;Medeiros;Jeffrey, L.;Chu;Chang-Yao;Chen;Peng-Chieh;Chang;Kung-Chao |
| 國立成功大學 |
2024-11 |
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis
|
D'Alessio;Antonio;Stefanini;Bernardo;Blanter;Julia;Adegbite;Benjamin;Crowley;Fionnuala;Yip;Vincent;Slater;Sarah;Fulgenzi;Maria, Claudia Angela;Celsa;Ciro;Manfredi;Francesca, Giulia;Pai;Madhava;Goldin;Robert;Ward;Stephen, C.;Fiel;Isabel, Maria;Shu;Daniel, H.;Su;Yung-Yeh;Cortellini;Alessio;Baretti;Marina;Anders;Robert;Yarchoan;Mark;Hsu;Chiun;Marron;Thomas, U.;Pinato;David, J. |
| 國立成功大學 |
2024-06-21 |
A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study
|
Tsai;Hui-Jen;Yang;Shih-Hung;Hsiao;Chin-Fu;Kao;Hsiang-Fong;Su;Yung-Yeh;Shan;Yan-Shen;Yen;Chia-Jui;Du;Jeng-Shiun;Hsu;Chiun;Wu;I-Chen;Chen;Li-Tzong |
| 國立成功大學 |
2024-06 |
Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation
|
Su;Yung-Yeh;Chiang;Nai-Jung;Chiu;Tai-Jan;Huang;Chien-Jui;Hsu;Shao-Jung;Lin;Hsin-Chen;Yang;Shih-Hung;Yang;Youngsen;Chou;Wen-Chi;Chen;Yen-Yang;Bai;Li-Yuan;Li;Chung-Pin;Chen;Jen-Shi |
| 國立成功大學 |
2024-05 |
Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer
|
Tang;Cheng-Yu;Yang;Shih-Hung;Li;Chung-Pin;Su;Yung-Yeh;Chiu;Sz-Chi;Bai;Li-Yuan;Shan;Yan-Shen;Chen;Li-Tzong;Chuang;Shih-Chang;Chan;De-Chuan;Yen;Chia-Jui;Peng;Cheng-Ming;Chiu;Tai-Jan;Chen;Yen-Yang;Chen;Jen-Shi;Chiang;Nai-Jung;Chou;Wen-Chi |
| 國立成功大學 |
2024-02-13 |
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan
|
Cheng;Muk, Siao;Su;Yung-Yeh;Chiang;Nai-Jung;Wang;Chih-Jung;Chao;Ying-Jui;Huang;Chien-Jui;Tsai;Hui-Jen;Chen;Shang-Hung;Chang;Chi-Yen;Tsai;Chia-Rung;Li;Yi-Jie;Yen;Chia-Jui;Chuang;Shih-Chang;Chang;Jeffrey, Shu-Ming;Shan;Yan-Shen;Hwang;Daw-Yang;Chen;Li-Tzong |
| 國立成功大學 |
2024-01-20 |
Qualification of major pathological response as a surrogate endpoint for relapse-free survival following neoadjuvant immunotherapy for hepatocellular carcinoma.
|
D'Alessio;Antonio;Stefanini;Bernardo;Blanter;Julia;Adegbite;Benjamin;Fulgenzi;Claudia, A. M.;Celsa;Ciro;Manfredi;Giulia, F.;Pai;Madhava;Goldin;Robert, D.;Shu;Daniel;Su;Yung-Yeh;Baretti;Marina;Anders;Robert, A.;Yarchoan;Mark;Hsu;Chiun;Marron;Urban, Thomas;Pinato;James, David |
| 國立成功大學 |
2023-09 |
The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study
|
Su;Yung-Yeh;Chao;Ying-Jui;Wang;Chih-Jung;Liao;Ting-Kai;Su;Ping-Jui;Huang;Chien-Jui;Chiang;Nai-Jung;Yu;Yu-Ting;Tsai;Hong-Ming;Chen;Li-Tzong;Shan;Yan-Shen |
| 國立成功大學 |
2023-06 |
Investigation into the content of red material in EUS-guided pancreatic cancer biopsies
|
Lin;Meng-Ying;Su;Yung-Yeh;Yu;Yu-Ting;Huang;Chien-Jui;Sheu;Bor-Shyang;Chang;Wei-Lun |
| 國立成功大學 |
2023-02 |
Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer
|
Su;Yung-Yeh;Chiang;Nai-Jung;Yang;Yi-Hsin;Yen;Chia-Jui;Bai;Li-Yuan;Chiu;Chang-Fang;Chuang;Shih-Chang;Yang;Shih-Hung;Chou;Wen-Chi;Chen;Jen-Shi;Chiu;Tai-Jan;Chen;Yen-Yang;Chan;De-Chuan;Peng;Cheng-Ming;Chiu;Sz-Chi;Li;Chung-Pin;Shan;Yan-Shen;Chen;Li-Tzong |
| 國立成功大學 |
2022-06-22 |
Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study
|
Su;Yung-Yeh;Chiang;Nai-Jung;Li;Chung-Pin;Yen;Chia-Jui;Yang;Shih-Hung;Chou;Wen-Chi;Chen;Jen-Shi;Chiu;Tai-Jan;Chen;Yen-Yang;Chuang;Shih-Chang;Bai;Li-Yuan;Chiu;Chang-Fang;Peng;Cheng-Ming;Chan;De-Chuan;Chiu;Sz-Chi;Yang;Yi-Hsin;Shan;Yan-Shen;Chen;Li-Tzong |
| 國立成功大學 |
2022-04-1 |
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study
|
Su;Yung-Yeh;Chiu;Yen-Feng;Li;Chung-Pin;Yang;Shih-Hung;Lin;Johnson;Lin;Shyh-Jer;Chang;Ping-Ying;Chiang;Nai-Jung;Shan;Yan-Shen;Ch'ang;Hui-Ju;Chen;Li-Tzong |
| 國立成功大學 |
2022 |
Original Article The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan
|
Yang;Shih-Hung;Chiang;Nai-Jung;Chiu;Sz-Chi;Chou;Wen-Chi;Bai;Li-Yuan;Li;Chung-Pin;Su;Yung-Yeh;Chiu;Tai-Jan;Chuang;Shih-Chang;Peng;Cheng-Ming;Chan;De-Chuan;Chen;Jen-Shi;Yen;Chia-Jui;Chen;Yen-Yang;Chiu;Chang-Fang;Chen;Li-Tzong;Shan;Yan-Shen |
| 國立成功大學 |
2021-08 |
Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives
|
Su;Yung-Yeh;Li;Chia-Chen;Lin;Yih-Jyh;Hsu;Chiun |
| 國立成功大學 |
2020-12-29 |
Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan
|
Chen;Chia-Yu;Liang;Shih-Hsin;Su;Yung-Yeh;Chiang;Nai-Jung;Wang;Hui-Ching;Chiu;Chang-Fang;Chen;Li-Tzong;Bai;Li-Yuan |
| 國立成功大學 |
2020-05-4 |
The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort
|
Su;Yung-Yeh;Chiang;Nai-Jung;Tsai;Hui-Jen;Yen;Chia-Jui;Shan;Yan-Shen;Chen;Li-Tzong |
| 國立成功大學 |
2019-10 |
Percutaneous Computed Tomography-Guided Coaxial Core Biopsy for the Diagnosis of Pancreatic Tumors
|
Su;Yung-Yeh;Liu;Yi-Sheng;Chao;Ying-Jui;Chiang;Nai-Jung;Yen;Chia-Jui;Tsai;Hong-Ming |
